Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cypros Pharmaceutical repurchases common stock.


CARLSBAD, Calif.--(BUSINESS WIRE)--Aug. 31, 1995--Cypros Pharmaceutical Corp. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:CYPR) announced Thursday that it has purchased and retired 280,000 shares of its outstanding common stock in a privately negotiated transaction, which included an additional 170,000 shares purchased by a group of individuals familiar with the company.

The 450,000 shares were purchased from Edwin Mishkin, trustee for the liquidation The collection of assets belonging to a debtor to be applied to the discharge of his or her outstanding debts.

A type of proceeding pursuant to federal Bankruptcy
 of the business of Adler Ad·ler , Alfred 1870-1937.

Austrian psychiatrist. He rejected Sigmund Freud's emphasis on sexuality and theorized that neurotic behavior is an overcompensation for feelings of inferiority.
 Coleman Clearing Corp. This transaction completes the liquidation of the approximate 1 million shares of Cypros common stock owned by the Adler bankruptcy bankruptcy, in law, settlement of the liabilities of a person or organization wholly or partially unable to meet financial obligations. The purposes are to distribute, through a court-appointed receiver, the bankrupt's assets equitably among creditors and, in most  trustee.

Paul J. Marangos, chief executive officer of the company, commented, "Over the past six weeks, the price of our stock has declined to an artificially low level. It has suffered from the public knowledge that the Adler trustee had a substantial number of shares of stock available for sale.

"This price decline has occurred despite our recent reported progress on the product acquisition, clinical trial commencement and patent prosecution Patent prosecution describes the interaction between an applicant, or their representative, and a patent office with regard to a patent, or an application for a patent. Broadly, patent prosecution can be split into pre-grant prosecution, which involves negotiation with a patent  fronts during that same period. However, the various sales by the trustee during the month of August did result in major institutional buying of Cypros common stock."

CONTACT: Cypros Pharmaceutical Corp.

David W. Nassif, 619/929-9500

or

Financial Sciences of America

Francesca Daniels, 310/278-4413
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 31, 1995
Words:205
Previous Article:Cypress To Split Stock.
Next Article:The Sharper Image reports higher August sales.
Topics:



Related Articles
Cypros Pharmaceutical extends special exercise period of Class A warrants.
Cypros Pharmaceutical raises $9.8 million in special warrant exercise program.
Cypros Pharmaceutical Corp. responds to decline in common-stock price.
Cypros Pharmaceutical Corp. announces listing of common stock and Class B warrants on NASDAQ National Market System.
Cypros Pharmaceutical Corp. announces a 2.5:1 stock split.
Cypros Pharmaceutical closes $7 million Regulation D private placement of convertible notes.
Cypros Pharmaceutical announces $5 million Regulation D private placement; Harvard College purchases more than 90 percent.
Cypros Pharmaceutical closes $5 million private placement to Harvard College.
Cypros Pharmaceutical closes $5 million private placement to Harvard College.
Cypros Pharmaceutical Raises $4.7 Million Through Partial Exercise Of Class B Warrants; Remainder Of Warrants Expire.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles